Skip to main content
Equibles

4554 · Fuji Pharma Co.,Ltd. · Financials

Use 4554 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 4554.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,878 JPY +27 (+1.46%) At close · Nov 12
Rebalance outlook locked
Market Cap
49.05B JPY
Shares
26.12M
Volume · Nov 12 158.1K Avg daily vol (3M) 119.13K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
51.68B +12%
FY2025 Revenue FY2021–FY2025
Net Income
3B -51.2%
FY2025 Net Income FY2021–FY2025
Gross Margin
40.18% +1.5pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
9.66% +1.2pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
5.8B +39.7%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 51.68B 46.14B 40.89B 35.43B 33.99B
JPY 30.91B 28.29B 24.37B 20.87B 19.24B
JPY 20.76B 17.84B 16.51B 14.56B 14.75B
JPY 4.99B 3.88B 3.86B 3.78B 3.35B
JPY 4B 8.28B 4.4B 3.72B 3.37B
JPY 1B 2.13B 963M 1.03B 938M
JPY 3B 6.15B 3.44B 2.7B 2.43B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: 4.44B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.